​

Takeda Pharmaceutical (TAK) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

TAK Stock Rating

Takeda Pharmaceutical stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (80.00%), 1 Hold (20.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 1 4 Strong Sell Sell Hold Buy Strong Buy

TAK Price Target Upside V Benchmarks

TypeNameUpside
StockTakeda Pharmaceutical-
SectorHealthcare Stocks 25.19%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.16%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$13.74$13.74$13.74
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25-31--4
Jan, 25-31--4
Dec, 24-31--4
Nov, 24131--5
Oct, 24131--5
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 10, 2024Johnson RiceBuyinitialise
Jul 24, 2024GuggenheimBuyinitialise
Jul 09, 2024Goldman SachsNeutralNeutralhold
Apr 04, 2023Cowen & Co.OutperformOutperformhold
Mar 16, 2023Bank of America SecuritiesBuyupgrade
Jul 19, 2022Cowen & Co.Outperformupgrade

Financial Forecast

EPS Forecast

$-50 $10 $70 $130 $190 $250 Mar 20 Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 20Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$28.41$240.72$147.14$92.09------
Avg Forecast$-48.10$85.99$75.36$100.23$44.62$41.59$74.60$98.84$130.73$151.39
High Forecast$-47.35$87.33$76.54$105.28$46.70$42.66$77.76$103.82$137.32$159.01
Low Forecast$-48.85$84.65$74.19$95.96$43.13$39.98$68.27$94.63$125.17$144.94
Surprise %-159.06%179.94%95.25%-8.12%------

Revenue Forecast

$3T $4T $4T $5T $5T $6T Mar 20 Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 20Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$3.29T$3.20T$3.57T$4.26T------
Avg Forecast$3.29T$3.27T$3.49T$3.98T$4.11T$4.66T$4.65T$4.72T$4.86T$5.03T
High Forecast$3.33T$3.31T$3.53T$4.13T$4.16T$4.67T$4.69T$4.91T$5.05T$5.22T
Low Forecast$3.25T$3.24T$3.45T$3.85T$4.07T$4.66T$4.60T$4.57T$4.70T$4.86T
Surprise %0.15%-2.35%2.25%7.11%------

Net Income Forecast

$-100B $0 $100B $200B $300B $400B Mar 20 Mar 21 Mar 22 Mar 24 Mar 25 Mar 26 Mar 27 Mar 28 Mar 29 Mar 30
Mar 20Mar 21Mar 22Mar 24Mar 25Mar 26Mar 27Mar 28Mar 29Mar 30
Reported$44.24B$376.00B$230.06B$144.07B------
Avg Forecast$-76.01B$135.89B$119.10B$158.40B$70.51B$65.72B$117.89B$156.20B$206.60B$239.24B
High Forecast$-74.83B$138.01B$120.96B$166.37B$73.80B$67.42B$122.89B$164.06B$217.01B$251.29B
Low Forecast$-77.20B$133.77B$117.24B$151.65B$68.16B$63.18B$107.89B$149.55B$197.80B$229.05B
Surprise %-158.20%176.70%93.16%-9.05%------

TAK Forecast FAQ

Is Takeda Pharmaceutical stock a buy?

Takeda Pharmaceutical stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Takeda Pharmaceutical is a favorable investment for most analysts.

What is Takeda Pharmaceutical's price target?

Takeda Pharmaceutical's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $13.74.

How does Takeda Pharmaceutical stock forecast compare to its benchmarks?

Takeda Pharmaceutical's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.19%) and underperforming the specialty & generic drug manufacturers stocks industry (34.16%).

What is the breakdown of analyst ratings for Takeda Pharmaceutical over the past three months?

  • February 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 75.00% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.

What is Takeda Pharmaceutical’s EPS forecast?

Takeda Pharmaceutical's average annual EPS forecast for its fiscal year ending in March 2025 is $44.62, marking a -51.55% decrease from the reported $92.09 in 2024. Estimates for the following years are $41.59 in 2026, $74.6 in 2027, $98.84 in 2028, $130.73 in 2029, and $151.39 in 2030.

What is Takeda Pharmaceutical’s revenue forecast?

Takeda Pharmaceutical's average annual revenue forecast for its fiscal year ending in March 2025 is $4.11T, reflecting a -3.51% decrease from the reported $4.26T in 2024. The forecast for 2026 is $4.66T, followed by $4.65T for 2027, $4.72T for 2028, $4.86T for 2029, and $5.03T for 2030.

What is Takeda Pharmaceutical’s net income forecast?

Takeda Pharmaceutical's net income forecast for the fiscal year ending in March 2025 stands at $70.51B, representing a -51.06% decrease from the reported $144.07B in 2024. Projections indicate $65.72B in 2026, $117.89B in 2027, $156.2B in 2028, $206.6B in 2029, and $239.24B in 2030.